ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,359Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 96

$841K Total Retail Price of All Prescriptions

Rank: 12 out of 96

509 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 509 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 14,671 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
FUROSEMIDE 776 763 1 4
LEVOTHYROXINE SODIUM 669 655 2 3
AMLODIPINE BESYLATE 588 575 3 2
DONEPEZIL HCL 442 418 4 8
NAMENDA 432 413 5 11
METOPROLOL TARTRATE 419 413 6 7
METOPROLOL SUCCINATE 394 387 7 9
WARFARIN SODIUM 393 358 8 6
LISINOPRIL 347 346 9 10
ATORVASTATIN CALCIUM 310 303 10 12
SIMVASTATIN 282 270 11 1
MIRTAZAPINE 249 246 12 14
ENALAPRIL MALEATE 247 224 13 28
ZOLPIDEM TARTRATE 220 206 14 18
OMEPRAZOLE 214 205 15 5
SANTYL 192 188 16 71
SERTRALINE HCL 191 156 17 15
LACTULOSE 186 134 18 37
OXYCODONE-ACETAMINOPHEN 172 138 S2 19 26
TAMSULOSIN HCL 160 155 20 29
GABAPENTIN 158 127 21 20
DIGOXIN 156 156 22 34
KLOR-CON M20 155 145 23 91
CITALOPRAM HBR 151 140 24 25
POTASSIUM CHLORIDE 147 146 25 19
TRAMADOL HCL 134 132 26 35
ESCITALOPRAM OXALATE 127 127 27 24
METFORMIN HCL 119 102 28 13
JANUVIA 118 117 29 49
ALENDRONATE SODIUM 116 105 30 36
QUETIAPINE FUMARATE 111 104 31 32
LEVOFLOXACIN 110 109 32 59
DIVALPROEX SODIUM 104 94 33 41
CLOPIDOGREL 101 100 34 27
LIDODERM 99 99 35 45
PANTOPRAZOLE SODIUM 97 97 36 44
PLAVIX 91 91 37 42
GLIPIZIDE 91 79 37 62
HYDRALAZINE HCL 90 88 39 79
SPIRIVA 88 88 40 67
SPS 85 85 41 210
FAMOTIDINE 84 76 42 21
FINASTERIDE 84 79 42 85
BACLOFEN 83 62 44 108
LOSARTAN POTASSIUM 81 81 45 23
LEVETIRACETAM 81 73 45 61
OXYBUTYNIN CHLORIDE ER 78 78 47 96
DIOVAN 78 78 47 17
CARBIDOPA-LEVODOPA 76 65 49 48
PRAVASTATIN SODIUM 75 74 50 33
CLONIDINE HCL 74 71 51 74
CYMBALTA 73 56 52 51
LATANOPROST 71 71 53 77
CARVEDILOL 70 69 54 22
PREDNISONE 66 65 55 58
PAROXETINE HCL 65 65 56 66
POLYETHYLENE GLYCOL 3350 64 63 57 53
TRAVATAN Z 62 56 58 79
RIVASTIGMINE 61 61 59 239
HYDROCHLOROTHIAZIDE 60 60 60 16
DILTIAZEM 24HR CD 60 60 60 83
RISPERIDONE 59 59 62 31
NYSTATIN 59 56 62 86
LANTUS 58 54 64 68
BUSPIRONE HCL 57 56 65 116
ROPINIROLE HCL 56 56 66 194
ATENOLOL 56 56 66 30
LIPITOR 55 50 68 63
NITROGLYCERIN PATCH 54 54 69 89
ADVAIR DISKUS 54 54 69 46
NIFEDIPINE ER 52 52 71 118
IPRATROPIUM-ALBUTEROL 51 51 72 57
SPIRONOLACTONE 50 50 73 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 14, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.